€106.22
0.26% today
Paris, Mar 13, 05:37 pm CET
ISIN
FR0000120578
Symbol
SAN
Sector
Industry

Sanofi Stock price

€106.22
+0.86 0.82% 1M
+2.82 2.73% 6M
+12.48 13.31% YTD
+17.73 20.04% 1Y
+13.81 14.94% 3Y
+33.24 45.55% 5Y
+16.92 18.94% 10Y
Paris, Closing price Thu, Mar 13 2025
+0.28 0.26%
ISIN
FR0000120578
Symbol
SAN
Sector
Industry

Key metrics

Market capitalization €132.81b
Enterprise Value €143.51b
P/E (TTM) P/E ratio 23.84
EV/FCF (TTM) EV/FCF 19.53
EV/Sales (TTM) EV/Sales 3.49
P/S ratio (TTM) P/S ratio 3.23
P/B ratio (TTM) P/B ratio 1.71
Dividend yield 3.55%
Last dividend (FY23) €3.76
Revenue growth (TTM) Revenue growth -4.62%
Revenue (TTM) Revenue €41.08b
EBIT (operating result TTM) EBIT €9.51b
Free Cash Flow (TTM) Free Cash Flow €7.35b
EPS (TTM) EPS €4.44
P/E forward 15.61
P/S forward 2.82
EV/Sales forward 3.05
Show more

Is Sanofi a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,808 stocks worldwide.

Sanofi Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Sanofi forecast:

20x Buy
83%
3x Hold
13%
1x Sell
4%

Analyst Opinions

24 Analysts have issued a Sanofi forecast:

Buy
83%
Hold
13%
Sell
4%

Financial data from Sanofi

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
41,081 41,081
5% 5%
100%
- Direct Costs 14,998 14,998
9% 9%
37%
26,083 26,083
2% 2%
63%
- Selling and Administrative Expenses 5,553 5,553
5% 5%
14%
- Research and Development Expense 7,394 7,394
10% 10%
18%
13,136 13,136
6% 6%
32%
- Depreciation and Amortization 3,630 3,630
25% 25%
9%
EBIT (Operating Income) EBIT 9,506 9,506
4% 4%
23%
Net Profit 5,560 5,560
3% 3%
14%

In millions EUR.

Don't miss a Thing! We will send you all news about Sanofi directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sanofi Stock News

AD HOC NEWS
about one month ago
Der französische Pharmakonzern Sanofi FR0000120578 kauft vom Kosmetikkonzern L'Oreal FR0000120321 eigene Aktien im Wert von rund drei Milliarden Euro zurück.
AD HOC NEWS
about one month ago
Der französische Pharmakonzern Sanofi FR0000120578 hat von dem französischen Kosmetikkonzern L'Oreal FR0000120321 eigene Aktien im Wert von rund drei Milliarden Euro zurückgekauft.
AD HOC NEWS
about one month ago
Beim Pharmakonzern Sanofi FR0000120578 soll sich der bereits vor Jahren eingeläutete Umbau in diesem Jahr auszahlen.
More Sanofi News

Company Profile

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Head office France
CEO Paul Hudson
Employees 84,587
Founded 1994
Website www.sanofi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today